Form 4 for KYNB KYNTRA BIO, INC.

Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-08 · accession 0001209191-23-018061 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-03-10	2023-03-08+	KYNB	Wettig Thane	Chief Commercial Off	S - Sale	$20.63	-13.9K	116.3K	-11%	-$287.5K
M	2023-03-10	2023-03-08	KYNB	Wettig Thane	Chief Commercial Off	A - Grant	$0.00	+15.1K	119.2K	+15%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-08	S	D	6,265	$21.16	104,090	D	—	—	(F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
2	Common	COmmon Stock	2023-03-08	A	A	5,799	$0.00	109,889	D	—	—	(F2) Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
3	Common	Common Stock	2023-03-10	S	D	4,731	$20.20	111,558	D	—	—	(F4) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.
4	Common	Common Stock	2023-03-08	A	A	9,338	$0.00	119,227	D	—	—	(F3) Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
5	Common	Common Stock	2023-03-10	S	D	2,938	$20.20	116,289	D	—	—	(F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.